106 related articles for article (PubMed ID: 7118473)
1. Clinical evaluation of ten-year survival cases after operation for upper and mid-thoracic esophageal cancer.
Kinoshita Y; Endo M; Nakayama K; Sato H; Sato H
Int Surg; 1982; 67(2):153-61. PubMed ID: 7118473
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ten-year survival after operation for upper- and mid-thoracic esophageal cancer.
Kinoshita Y; Endo M; Nakayama K; Sato H; Sato H
Int Adv Surg Oncol; 1978; 1():173-200. PubMed ID: 553036
[TBL] [Abstract][Full Text] [Related]
3. [Surgery for upper or middle thoracic esophageal carcinoma after gastrectomy].
Cheng BC; Xia J; Mao ZF; Huang J; Wang ZW; Wang TS; Deng HP
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):909-12. PubMed ID: 16083619
[TBL] [Abstract][Full Text] [Related]
4. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
5. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
[TBL] [Abstract][Full Text] [Related]
9. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
10. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
11. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
12. [Endoscopic mucosal resection for esophageal cancer].
Momma K; Yoshida M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):914-9. PubMed ID: 12894703
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic evaluation of lymph node metastasis in thoracic esophageal cancer--an analysis of 212 cases].
Chen JH; Wei GQ; Chen MY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):441-3. PubMed ID: 7720501
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for carcinoma of the esophagus in the elderly patient.
Xijiang Z; Xizeng Z; Xishan H; Hongjing J
Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):182-6. PubMed ID: 10413765
[TBL] [Abstract][Full Text] [Related]
15. [Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma].
Xiao ZF; Yang ZY; Wang LH; Zhang HX; Feng QF; Chen DF; Zhou ZM; Zhang DC; Sun KL; Cheng GY; He J
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):112-5. PubMed ID: 15059333
[TBL] [Abstract][Full Text] [Related]
16. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
18. [Progress in surgical treatment of carcinoma of the intrathoracic esophagus].
Kakegawa T; Yamana H
Gan To Kagaku Ryoho; 1995 Jun; 22(7):855-62. PubMed ID: 7793992
[TBL] [Abstract][Full Text] [Related]
19. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
20. Determination of the irradiation field for clinical T1-T3N0M0 thoracic/abdominal esophageal cancer based on the postoperative pathological results.
Nakamura T; Hatooka S; Kodaira T; Tachibana H; Tomita N; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Shinoda M; Fuwa N
Jpn J Clin Oncol; 2009 Feb; 39(2):86-91. PubMed ID: 19042946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
